Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 7, 2017
A human case of travel-related rabies in Austria, September 2004R Strauss, A Gränz, M Wassermann-Neuhold, et al.British Journal of Cancer|October 11, 2012
Brain-only metastatic breast cancer is a distinct clinical entity characterised by favourable median overall survival time and a high rate of long-term survivorsA S Berghoff, Z Bago-Horvath, A Ilhan-Mutlu, et al.British Journal of Cancer|December 1, 2011
Impact of anti-HER2 therapy on overall survival in HER2-overexpressing breast cancer patients with brain metastasesR Bartsch, A Berghoff, U Pluschnig, et al.Breast Cancer Research and Treatment|April 25, 2016
Prognostic impact of breast cancer subtypes in elderly patientsE S Bergen, C Tichy, A S Berghoff, et al.ESMO Open|January 5, 2021
A clinical validation study of MammaPrint in hormone receptor-positive breast cancer from the Austrian Breast and Colorectal Cancer Study Group 8 (ABCSG-8) biomarker cohortP Dubsky, L Van't Veer, M Gnant, et al.ESMO Open|August 9, 2021
ESR1, PGR, ERBB2, and MKi67 mRNA expression in postmenopausal women with hormone receptor-positive early breast cancer: results from ABCSG Trial 6M Filipits, M Rudas, C F Singer, et al.British Journal of Cancer|January 12, 2012
Brain metastases free survival differs between breast cancer subtypesA Berghoff, Z Bago-Horvath, C De Vries, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2013
Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy aloneM Gnant, M Filipits, R Greil, et al.Pageof 2